Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Bladder cancer is the fourth most common cancer in men in the U.S. and the 10th most common in women. It usually occurs in patients over 68 years of age, so a noninvasive way to evaluate cases in elderly patients could lower risks of complications.
Dr. Ercan Kocakoc and colleagues in the departments of radiology and urology at Firat University in Elazig, Turkey, published their study in the January issue of the Journal of Ultrasound in Medicine. They examined 31 patients with confirmed or suspected bladder cancer using 3D ultrasound within 15 days of conventional cystoscopy and compared the results.
Each ultrasound exam included gray-scale, 3D virtual, and multiplanar reconstruction images, which the researchers evaluated for the number, size, location, and morphologic features of lesions, providing a virtual cystoscopy.
The researchers obtained good or excellent image quality on 28 of the 31 virtual cystoscopies, or 90.3%. Conventional cystoscopy found 47 lesions in 22 patients. Virtual cystoscopy showed 41 or 87.2% of these 47 lesions.
For tumor detection, 3D sonography alone had a 96.2% sensitivity, 70.6% specificity, positive predictive value of 93.9%, and negative predictive value of 80%. A combination of gray-scale sonography, multiplanar reconstruction, and 3D virtual sonography detected tumors with a sensitivity of 96.4%, specificity of 88.8%, positive predictive value of 97.6%, and negative predictive value of 84.2%.
The researchers concluded that 3D ultrasound could be a promising noninvasive alternative to conventional methods of detecting bladder cancer, since the results of virtual cystoscopy agreed well with conventional cystoscopy.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.